Search

Your search keyword '"T cells -- Comparative analysis"' showing total 146 results

Search Constraints

Start Over You searched for: Descriptor "T cells -- Comparative analysis" Remove constraint Descriptor: "T cells -- Comparative analysis" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
146 results on '"T cells -- Comparative analysis"'

Search Results

1. Data on Cell Therapy Discussed by a Researcher at HCA Healthcare [Comparison of 15- Vs. 30-Day Remote Patient Monitoring for Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System]

2. Soligenix's HyBryte shows higher efficacy in comparative lymphoma study

Catalog

Books, media, physical & digital resources

3. Reports on B-Cell Lymphoma Findings from Princess Margaret Cancer Centre Provide New Insights (A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, ...)

5. ADAMTS7 Attenuates House Dust Mite-Induced Airway Inflammation and Th2 Immune Responses

6. Data on Influenza A Virus Published by Researchers at Institute of Experimental Medicine (Comparative analysis of the conservation of nucleoprotein immunogenic T-cell epitopes of master donor viruses for live and inactivated influenza vaccines)

7. A Comparative assessment of T-Cell response of Healthy donors and Acute Graft-versus-Host-Disease Patients: Customizing immune monitoring platform

8. Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte(TM) Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma

9. Researchers' from Tehran University of Medical Sciences Report Details of New Studies and Findings in the Area of Human T-Lymphotropic Virus (Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals)

10. University Hospital 12 de Octubre Researcher Provides New Data on Leukemia (Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells)

11. Study Findings on Multiple Myeloma Reported by Researchers at Memorial Sloan-Kettering Cancer Center (Comparison of infectious complications with BCMA-directed therapies in multiple myeloma)

12. Reports Summarize HIV/AIDS Study Results from University of California Los Angeles (UCLA) (Stem Cell-derived Car T Cells Show Greater Persistence, Trafficking, and Viral Control Compared To ex Vivo transduced Car T Cells)

13. Abecma delivers sustained progression-free survival versus standard regimens in earlier lines of therapy for relapsed and refractory multiple myeloma based on longer-term follow-up from KarMMa-3

14. New B-Cell Lymphoma Research Has Been Reported by a Researcher at Inha University Hospital (Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis)

15. Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis

16. Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation

18. New Findings from University of Edinburgh in the Area of Chronic Fatigue Syndrome Published (Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls)

19. Findings from Second Hospital of Shandong University Provides New Data on Aplastic Anemia (Cd4+t-cell Subsets In Aplastic Anemia, Myelodysplastic Syndrome, and Acute Myelogenous Leukemia Patients: a Comparative Analysis)

20. Kite's Tecartus CAR T-cell therapy demonstrates 78% complete response rate and 90% overall response rate in largest real-world evidence analysis for relapsed/refractory mantle cell lymphoma

21. Kite's Tecartus CAR T-cell therapy demonstrates 78% complete response rate and 90% overall response rate in largest real-world evidence analysis for relapsed/refractory mantle cell lymphoma

22. Kite's Yescarta CAR T-cell therapy demonstrates significantly longer overall survival versus standard of care as initial treatment of relapsed/refractory large B-cell lymphoma

23. New COVID-19 Study Findings Recently Were Published by a Researcher at Institute for Experimental Immunology (B-108 T-cell-mediated Immunity against SARS-CoV-2 in Health Care Workers: Head-to-head Comparison of Two Interferon-Gamma Release ...)

24. Cell responses to simulated microgravity and hydrodynamic stress can be distinguished by using comparative transcriptomic analysis

25. New Science Signaling Study Results from Fred Hutchinson Cancer Research Center Described (Comparative Analysis of Tcr and Car Signaling Informs Car Designs With Superior Antigen Sensitivity and In Vivo Function)

27. Investigators from National Cancer Institute (NCI) Release New Data on Immunologic Receptors (A Comparison of Chimeric Antigen Receptors Containing Cd28 Versus 4-1bb Costimulatory Domains)

28. Abecma (idecabtagene vicleucel) reduced the risk of disease progression or death by 51% versus standard regimens in earlier lines of therapy for relapsed and refractory multiple myeloma based on results from Phase 3 KarMMa-3 study

29. The major advantages and early clinical obstacles of CAR-NK compared to CAR-T cell therapy

30. Comparative Multiomic Analysis Reveals Low T Cell Infiltration as the Primary Feature of Tobacco Use in HPV(+) Oropharyngeal Cancer

31. Studies from National University of Singapore Update Current Data on Cancer Research (Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model)

32. New analyses of Kite's Tecartus CAR T-cell therapy provide additional evidence supporting overall survival and durability of response

33. Researchers' Work from Peking University Cancer Hospital and Institute Focuses on Solid Cancer (Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study)

34. Regional Institute of Ophthalmology Researchers Focus on Keratoconjunctivitis (A Comparative Evaluation of Tacrolimus versus Steroids in the Treatment of Vernal Keratoconjunctivitis)

35. Comparative single-cell trajectory network enrichment identifies pseudo-temporal systems biology patterns in hematopoiesis and CD8 T-cell development (Updated April 6, 2020)

36. Research from Institute for Experimental Immunology Yields New Data on COVID-19 (Comparison of Two Commercially Available Interferon-g Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in ...)

38. University of Rochester Details Findings in Developmental and Comparative Immunology (A Xenopus Tadpole Alternative Model To Study Innate-like T Cell-mediated Anti-mycobacterial Immunity)

39. Technical University Munich (TU Munich) Researchers Update Understanding of Hepatitis B Virus (Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor ...)

40. Studies from University of Pittsburgh Have Provided New Information about Lupus (Sex-based Comparison of Cd4+t Cell Dna Methylation In Lupus Reveals Proinflammatory Epigenetic Changes In Men)

41. Study Findings from Yonsei University Broaden Understanding of Vaccines [Bcg Delta Bcg1419c Increased Memory Cd8(+) T Cell-associated Immunogenicity and Mitigated Pulmonary Inflammation Compared With Bcg In a Model of Chronic Tuberculosis]

42. Comparative multi-OMICS single-cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action

43. Novel CAR-T cell approaches of Chinese pharma promote clinical innovation and can address remaining unmet needs, says GlobalData

44. Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel) significantly improves outcomes, showing superiority over 20-year standard of care in second-line relapsed or refractory large B-cell lymphoma based on TRANSFORM study results

45. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque

46. Data on HIV/AIDS Discussed by Researchers at National Cancer Institute Frederick (Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques)

47. New T-Cell Lymphoma Research from Beth Israel Deaconess Medical Center Discussed (Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis)

48. Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Compared to TIGIT and PD-1

49. Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Compared to TIGIT and PD-1 as a Novel Checkpoint on the DNAM Axis at SITC 2021